Results: The predicted percentage value of FEF 
Departments of Respiratory and Critical Care Medicine, Chronic Airways Diseases Laboratory, Nanfang Hospital, Southern Medical University, Guangzhou, China Background and Aims: In vivo, we aimed to determine whether cigarette smoking can promote ACEII senescence and aggravate bleomycin (BLM) induced pulmonary fibrosis in mice; in vitro, to explore the mechanisms underlying ACEII senescence following cigarette smoke extract (CSE) treatment.
Methods: In vivo, 60 male C57 mice were randomly divided into three groups: control, BLM and BLM+cigarette smoking. In control and BLM group, 100 μL sterile saline and equivalent sterile saline containing BLM at a single dose of 5 mg/kg were administered, respectively; in BLM+cigarette smoking group, following treated with BLM, mice were exposed to 5 commercial filtered cigarettes for 1 h each time, 2 times a day(respectively in the morning and afternoon) for 4 weeks. 4 weeks later, lung tissues were harvest and H&E, Massom's trichrome were performed and Ashcroft score were assessed. The expression of SPC, p16 and p21 were detected by immunohistochemistry. In vitro, mouse AECII strain MLE-12 were stimulated respectively with 0.05%, 0.1%, 0.25%, 0.5%, 1% CSE for 36 h and H 2 O 2 stimulation as positive control. The cellular senescence were evaluated with β-galactosidase staining and western blot analysis of p16 and p21. The protein level of p62 and LC3 were also detected. The cells were treated with or without 3-methyladenine (3-MA), bafilomycin (BA) and rapamycin (RAPA) following CSE stimulation and senescence rate were evaluated.
Results: Compared with BLM group, the masson staining and Ashcroft score were upregulated significantly in BLM+cigarette smoking group, accompanied with elevation expression of p16 and p21 in SPCpositive cells. The senescence markers including β-galactosidase, p16 and p21 were increased after CSE stimulation at a concentration of 0.5% and the conversion of LC3I to LC3II were blocked. 3-MA, BA and RAPA had no significant impact on senescence rate.
Conclusion:
Cigarette can aggravate pulmonary fibrosis by inducing alveolar epithelial cell II senescence, which may be mediated by abnormal autophagy flux. Background and Aims: To test the effectiveness of combined a heart rate variability biofeedback (HRVBF) with PR on improving physiological and psychological well-being, adherence to regular exercise, and further improving the quality of life in patients with COPD.
Methods: This was a randomized controlled trial. Subjects were recruited from a Medical Center in Taiwan, and randomly divided into usual care (sham group), PR alone (PR group), or combined PR and HRVBF group (PR-HRVBF group). All subjects received twice a week supervised hospital training and a weekly unsupervised home training for four weeks. We compared pre-, post-training, 12-week and 24-week follow-ups of psychophysiological indices among three groups Results: Thirty-six subjects completed the participation. The PR-HRVBF groups had significantly higher adherence to regular exercise at 12-week follow-up than the other two groups (χ 2 = 12.6, P = 0.01). Both PR and PR-HRVBF groups had higher quality of life in physical component than usual care group (P = 0.05) at 12-week follow-up. The PR-HRVBF group showed significantly decreasing depression, improving SF12-MCS (P < .05), 6MWD (P < 0.05), HRV (P < 0.05), and 6MWD after 4 weeks training and 12-week follow-up. The PR group presented significantly decreasing dyspnea (P < 0.05), improving SF12-PCS (P < .01), and HRV-TP (P < 0.05) after 4 weeks training, but decreasing dyspnea (P < 0.05), anxiety (P < 0.05), and depression, improving SF12-PCS (P < .01), and HRV (P < 0.01) significantly changed at12-week follow-up. In sham group, all psychophysiological indices did not significantly change at any time
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